Kevin M. Sun - Mar 5, 2024 Form 4/A Insider Report for DermTech, Inc. (DMTK)

Role: Chief Financial Officer
Signature: /s/ Jason S. Miller, attorney-in-fact
Stock symbol: DMTK
Transactions as of: Mar 5, 2024
Transactions value $: $0
Form type: 4/A
Date filed: 3/12/2024, 08:11 PM
Date Of Original Report: Mar 7, 2024
Previous filing: Dec 11, 2023
Next filing: Mar 12, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	DMTK	Common Stock						275K	Mar 5, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 7, 2024, the reporting person filed a Form 4, which inadvertently omitted from the amounts of securities beneficially owned following the reported transactions in column 5 of such Form 4 the 2,500 shares acquired under the issuer's Employee Stock Purchase Plan on February 29, 2024 (as described in footnote 2 of such Form 4). In fact, as reported in this amendment, following such transactions the reporting person beneficially owned 275,051 shares of common stock of the issuer.

Content

On March 7, 2024, the reporting person filed a Form 4, which inadvertently omitted from the amounts of securities beneficially owned following the reported transactions in column 5 of such Form 4 the 2,500 shares acquired under the issuer's Employee Stock Purchase Plan on February 29, 2024 (as described in footnote 2 of such Form 4). In fact, as reported in this amendment, following such transactions the reporting person beneficially owned 275,051 shares of common stock of the issuer.